Summary
- Current Price
- As of today, NSRX price is $5.00, down -6.37% on
- Current Price All-Time High
- NSRX price is currently -49.95% below its historical high of $9.99 set on
- Market Cap
- NSRX current market cap is $45M, with unknown 1-year change
- PE Ratio
- NSRX PE ratio is unknown
- Revenue
- NSRX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for NSRX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Nasus Pharma Ltd. |
| Ticker | NYSEAmerican: NSRX |
| Exchange | NYSE American |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | Israel |
| IPO | |
| Indexes | Not included |
| Website | nasuspharma.com |
| Employees | 1 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $5.00 | ||
| Price, 1D Change | -6.37% | |
| $45M | ||
| - | ||
| - | ||
| -0.38 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.05 | ||
| EPS, 1Y Change | -45.08% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.05 | ||
| EPS Estimate | N/A | -$0.69 |
| EPS Est. Change | N/A | -1,398.91% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $5.00 | ||
| Price Target | - | $20.50 |
| Price Tgt. Change | - | +310.00% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.69 | N/A | - | |
| -$1.58 | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| 0.00% | ||
| 0.00% | ||
| -45.08% | ||
| +18.68% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $5.00 | ||
| $7.24 | ||
| SMA 200 vs Price | +44.87% | |
| $6.56 | ||
| SMA 50 vs Price | +31.28% | |
| -0.38 | ||
| $0.63 | ||
| 36.47 | ||
| 74.75% | ||
| 77.77% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.05 | ||
| $0.00 | ||
| - | ||
| -$291.20K | ||
| - | ||
| -$419.30K | ||
| - | ||
| -$291.20K |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -0.56 | ||
| 0.12 | ||
| 0.12 | ||
| - | ||
| - | ||
| -10.21 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| -14.10 | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$881.50K | ||
| $85.40K | ||
| $196.80K | ||
| $125.40K | ||
| $1.08M | ||
| $1.08M | ||
| $494.60K | ||
| $494.60K | ||
| $178.70K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $419.30K | ||
| $291.20K | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$179.60K | ||
| $0.00 | ||
| $208.00K | ||
| $0.00 | ||
| -$179.60K |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Citizens | ||
| Laidlaw & Co. |
Analyst sentiment
Institutional ownership
Screeners with NSRX
FAQ
What is the ticker symbol for Nasus Pharma Ltd.?
The ticker symbol for Nasus Pharma Ltd. is NYSEAmerican:NSRX
Does Nasus Pharma Ltd. pay dividends?
No, Nasus Pharma Ltd. does not pay dividends
What sector is Nasus Pharma Ltd. in?
Nasus Pharma Ltd. is in the Healthcare sector
What industry is Nasus Pharma Ltd. in?
Nasus Pharma Ltd. is in the General Drug Manufacturers industry
What country is Nasus Pharma Ltd. based in?
Nasus Pharma Ltd. is headquartered in Israel
When did Nasus Pharma Ltd. go public?
Nasus Pharma Ltd. initial public offering (IPO) was on August 13, 2025
Is Nasus Pharma Ltd. in the S&P 500?
No, Nasus Pharma Ltd. is not included in the S&P 500 index
Is Nasus Pharma Ltd. in the NASDAQ 100?
No, Nasus Pharma Ltd. is not included in the NASDAQ 100 index
Is Nasus Pharma Ltd. in the Dow Jones?
No, Nasus Pharma Ltd. is not included in the Dow Jones index
When does Nasus Pharma Ltd. report earnings?
The date for Nasus Pharma Ltd.'s next earnings report has not been announced yet
Data Sources & References
- NSRX Official Website www.nasuspharma.com
- NSRX Profile on Yahoo Finance finance.yahoo.com/quote/NSRX
- NSRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nsrx